Association of pathologic factors with postoperative venous thromboembolism after gastrointestinal cancer surgery.

[1]  D. Bentrem,et al.  Venous Thromboembolism Chemoprophylaxis Adherence Rates After Major Cancer Surgery , 2023, JAMA network open.

[2]  Sean Stevens,et al.  Optimal Timing of Perioperative Chemical Thromboprophylaxis in Elective Major Abdominal Surgery , 2022, Annals of surgery.

[3]  R. Bold,et al.  Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery. , 2022, JAMA surgery.

[4]  S. Stevens,et al.  Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. , 2021, Chest.

[5]  A. Artoni,et al.  Thrombotic risk in gastroenteropancreatic neuroendocrine tumor patients: a single-center experience , 2021, Annals of gastroenterology.

[6]  D. Bentrem,et al.  Development and validation of a risk calculator for post-discharge venous thromboembolism following hepatectomy for malignancy. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[7]  D. Bentrem,et al.  Post-discharge venous thromboembolism after pancreatectomy for malignancy: Predicting risk based on preoperative, intraoperative, and postoperative factors. , 2020, Journal of surgical oncology.

[8]  C. Flowers,et al.  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Bentrem,et al.  Pre-Operative, Intra-Operative, and Post-Operative Factors Associated with Post-Discharge Venous Thromboembolism Following Colorectal Cancer Resection , 2019, Journal of Gastrointestinal Surgery.

[10]  J. Canner,et al.  Justifying Total Costs of Extended Venothromboembolism Prophylaxis After Colorectal Cancer Surgery , 2019, Journal of Gastrointestinal Surgery.

[11]  Jonathan M. Hernandez,et al.  Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons , 2019, Journal of Thrombosis and Thrombolysis.

[12]  Kimberly A. Cradock,et al.  Multi-institution Evaluation of Adherence to Comprehensive Postoperative VTE Chemoprophylaxis , 2019, Annals of surgery.

[13]  Weiming Hu,et al.  Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis. , 2019, Thrombosis research.

[14]  P. Metharom,et al.  Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment , 2018, Cancers.

[15]  J. Douketis,et al.  Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. , 2018, The Cochrane database of systematic reviews.

[16]  K. Bilimoria,et al.  Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis , 2015, Medical care.

[17]  F. Vázquez,et al.  Improving Adherence Rate of Extended Prophylaxis for Venous Thromboembolic Disease After Abdominal and Pelvic Oncologic Surgery , 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[18]  N. Nguyen,et al.  A Nationwide Analysis of Postoperative Deep Vein Thrombosis and Pulmonary Embolism in Colon and Rectal Surgery , 2014, Journal of Gastrointestinal Surgery.

[19]  D. Bentrem,et al.  Adherence With Postdischarge Venous Thromboembolism Chemoprophylaxis Recommendations After Colorectal Cancer Surgery Among Elderly Medicare Beneficiaries , 2014, Annals of surgery.

[20]  C. Ko,et al.  Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. , 2013, JAMA.

[21]  Justin B Dimick,et al.  Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. , 2013, Journal of the American College of Surgeons.

[22]  D. Dunkler,et al.  Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Fraker,et al.  Incidence of venous thromboembolism in patients undergoing surgical treatment for malignancy by type of neoplasm: An analysis of ACS-NSQIP data from 2005 to 2010. , 2012, Surgery.

[24]  M. Corriere,et al.  Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. , 2011, Journal of vascular surgery.

[25]  G. Lyman.  Venous thromboembolism in the patient with cancer , 2011, Cancer.

[26]  C. Ko,et al.  Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. , 2010, Advances in surgery.

[27]  P. Prandoni,et al.  Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study , 2010, Journal of thrombosis and haemostasis : JTH.

[28]  A. Khorana,et al.  Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. , 2010, Thrombosis research.

[29]  S. Goldhaber,et al.  Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey): Findings in Surgical Patients , 2010, Annals of surgery.

[30]  W. Henderson,et al.  Design and statistical methodology of the National Surgical Quality Improvement Program: why is it what it is? , 2009, American journal of surgery.

[31]  T. Wakefield,et al.  Venous Thromboembolism in Cancer Patients Undergoing Major Surgery , 2008, Annals of Surgical Oncology.

[32]  L. Jørgensen,et al.  Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open‐label study , 2006, Journal of thrombosis and haemostasis : JTH.

[33]  F. Parazzini,et al.  A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery: The @RISTOS Project , 2006, Annals of surgery.

[34]  A. Cohen,et al.  Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. , 2002, The New England journal of medicine.

[35]  M. Menon,et al.  Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. , 2014, JAMA surgery.

[36]  C. Ko,et al.  Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. , 2010, Journal of the American College of Surgeons.

[37]  Tufia C Haddad,et al.  Chemotherapy-induced thrombosis. , 2006, Thrombosis research.